2018
DOI: 10.1097/sla.0000000000002902
|View full text |Cite
|
Sign up to set email alerts
|

The Comprehensive Complication Index (CCI®) is a Novel Cost Assessment Tool for Surgical Procedures

Abstract: The aim of this study was to identify a readily available, reproducible, and internationally applicable cost assessment tool for surgical procedures. SUMMARY OF BACKGROUND DATA Strong economic pressure exists worldwide to slow down the rising of health care costs. Postoperative morbidity significantly impacts on cost in surgical patients. The comprehensive complication index (CCI), reflecting overall postoperative morbidity, may therefore serve as a new marker for cost. METHODS Postoperative complications and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
82
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 73 publications
(85 citation statements)
references
References 14 publications
(12 reference statements)
2
82
0
1
Order By: Relevance
“…29,30 Cost estimation was performed based on recipient age and 90-day CCI score, according to Staigner et al, using a validated online cost-assessment tool for OLT (URL: https ://www.asses surge ry.com/cost-prediction/). 31 Recipient pre-OLT performance status has been assessed using the Karnofsky performance score (KPS). 32 Postoperative transfusions were defined as any blood products given within the first 7 days following OLT.…”
Section: Data Collection and Follow-upmentioning
confidence: 99%
“…29,30 Cost estimation was performed based on recipient age and 90-day CCI score, according to Staigner et al, using a validated online cost-assessment tool for OLT (URL: https ://www.asses surge ry.com/cost-prediction/). 31 Recipient pre-OLT performance status has been assessed using the Karnofsky performance score (KPS). 32 Postoperative transfusions were defined as any blood products given within the first 7 days following OLT.…”
Section: Data Collection and Follow-upmentioning
confidence: 99%
“…Patients excluded from the "low-risk" group had a history of previous intraabdominal surgery, cardiovascular disease (e.g., cardiac arrhythmia, stroke, coronary artery disease), history of thromboembolic events and/or therapeutic anticoagulation, diabetes mellitus (type 1 and type 2, as defined by the American Diabetes Association), obstructive sleep apnea (recurrent episodes of upper airway collapse during sleep), chronic obstructive pulmonary disease (FEV1/ FVC < 0.7), chronic kidney disease (eGFR < 30 mL/min/1.72 m2), inflammatory bowel disease (ulcerative colitis, Crohn's disease), immunosuppression therapy (i.e., steroids, calcineurin inhibitors), or associated surgical procedures (i.e., cholecystectomy, hiatoplasty, liver biopsy). Costs were estimated for patients with or without any surgical complications by using the algorithm developed by Staiger et al [24].…”
Section: Study Population and Designmentioning
confidence: 99%
“…Coupled to a recent study published in this journal showing a close correlation between CCI 1 and costs, we would expect that the financial burden for PD extends up to 6 months after surgery, which should be taken into account for proper reimbursement. 43 To illustrate the applicability of the established benchmark cutoffs for outcome comparisons with other cohorts undergoing PD, we first analyzed nearly thousand patients, only differing from the benchmark cases by a poorer preoperative physical status (ASA class !3). In this cohort, morbidity rates increased but stayed within the benchmark cutoffs.…”
Section: Discussionmentioning
confidence: 99%